Primary Care Diabetes
Volume 2, Issue 1 , Pages 17-23 , 2008

Personal impact of type 2 diabetes decreased over 5 years: Implications for motivating patients

  • Tim Kenealy

      Affiliations

    • University of Auckland, South Auckland Clinical School, Middlemore Hospital, Private Bag 93311, Otahuhu, Auckland 6, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 9 2760044x8415; fax: +64 9 2760066.
    • ,
  • Campbell Kyle

      Affiliations

    • Diagnostic MedLab, Auckland, New Zealand
    • ,
  • David Simmons

      Affiliations

    • Cambridge University Hospitals NHS Foundation Trust, United Kingdom

Received 29 July 2007 ,Revised 26 October 2007 ,Accepted 30 October 2007.

References 

  1. International Diabetes Federation . Diabetes Atlas. 3rd ed.. Brussels: International Diabetes Federation; 2007;
  2. Garratt A, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet. Med. 2002;19:1–11
  3. Singh D. Transforming Chronic Care. Evidence about Improving Care for People with Long-term Conditions. Birmingham: University of Birmingham Health Services Management Centre; 2005;
  4. Masaki Y, Okada S, Ota Z. Importance of attitude evaluation in diabetes patient education. Diabet. Res. Clin. Pract. 1990;8:37–44
  5. Maiman L, Becker M. The Health Belief Model: origins and correlates in psychological theory. In:  Becker M editors. The Health Belief Model and Personal Health Behavior. Thorofare, New Jersey: Charles B Slack Inc.; 1974;p. 9–26
  6. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. Br. Med. J. 2002;324:1417–1420
  7. UK Prospective Diabetes Study Group, UK Prospective Diabetes Study 16, Overview of 6 years’ therapy of type II diabetes: a progressive disease, Diabetes 44 (1995) 1249–1258.
  8. Adriaanse M, Dekker J, Spijkerman A, et al. Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabet. Med. 2004;21:1075–1081
  9. UKPDS Study Group . Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 1999;22:1125–1136
  10. Simmons D, Schaumkel J, Cecil A, et al. High impact of nephropathy on five-year mortality rates among patients with type 2 diabetes patients from a multi-ethnic population in New Zealand. Diabet. Med. 1999;16:926–931
  11. Simmons D, Shaw L, Scott D, et al. Diabetic nephropathy and microalbuminuria in the community. Diabetes Care. 1994;17:1404–1409
  12. Simmons D, Scott D, Kenealy T, Scragg R. Foot Care among diabetic patients in South Auckland. NZ Med. J. 1995;108:106–108
  13. G. Rose, H. Blackburn, Cardiovascular survey methods. Monograph Series No. 56. In: World Health Organization, Geneva, 1968.
  14. Scragg R, Baker J, Metcalf P, Dryson E. Serum lipid levels in a New Zealand multicultural workforce. NZ Med. J. 1993;106:96–99
  15. Dunn S, Smart H, Beeney L, Turtle J. Measurement of emotional adjustment in diabetic patients: validity and reliability of ATT39. Diabetes Care. 1986;9:480–489
  16. Simmons D, Shaw L, Kenealy T, Scragg R. Ethnic differences in diabetes knowledge and education: The South Auckland Diabetes Survey. NZ Med. J. 1994;107:197–200
  17. Simmons D, Gatland B, Fleming C, et al. Prevalence of known diabetes in a multiethnic community. NZ Med. J. 1994;107:219–222
  18. Simmons D, Kenealy T, Scott D. Implementing the South Auckland Diabetes Plan: barriers and lessons. NZ Med. J. 2000;113:364–366
  19. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977–986.
  20. Lewis E, Hunsicker L, Bain R, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 1993;329:1456–1463
  21. Sprangers M, Schwartz C. Integrating response shift into health-related quality of life research: a theoretical model. Soc. Sci. Med. 1999;48:1507–1515
  22. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc. Sci. Med. 1999;48:1531–1548
  23. Wilson IB. Clinical understanding and clinical implications of response shift. Soc. Sci. Med. 1999;48:1577–1588
  24. Campbell R, Pound P, Pope C, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc. Sci. Med. 2003;56:671–684
  25. Prochaska J, Velicer W, Rossi J, et al. Stages of change and decisional balance for 12 problem behaviours. Health Psychol. 1994;13:39–46
  26. Kenealy T, Arroll B, Kenealy H, et al. Diabetes care: practice nurse roles, attitudes and concerns. J. Adv. Nurs. 2004;48:68–75
  27. Woodcock A, Kinmonth A. Patient concerns in their first year with type 2 diabetes: patient and practice nurse views. Patient Educ. Couns. 2001;42:257–270

PII: S1751-9918(07)00153-2

doi: 10.1016/j.pcd.2007.10.045

Primary Care Diabetes
Volume 2, Issue 1 , Pages 17-23 , 2008

Article Tools